For Immediate Release; Approval of the 1st and only Long Acting Injectable PrEP.

ICWEA Congratulates ViiV HealthCare upon the Approval of the 1st   only long-acting injectable pre-exposure prophylaxis (PrEP) option to reduce HIV acquisition risk - Yet another Discreet HIV prevention Option for…

Continue ReadingFor Immediate Release; Approval of the 1st and only Long Acting Injectable PrEP.

ICWEA calls for increased investment in Community led responses to end TB

http://www.icwea.org/wp-content/uploads/downloads/2017/03/World-Tuberculosis-Day-2017-ICWEA-Statement-Ds-edit-1.pdf As we commemorate the World Tuberculosis (TB) Day 2017, under the theme, Unite to End TB, the International Community of Women Living with HIV calls for increased investment in gender,…

Continue ReadingICWEA calls for increased investment in Community led responses to end TB

WHO RELEASES GUIDANCE ON HORMONAL CONTRACEPTIVE ELIGIBILITY FOR WOMEN LIVING AT HIGH RISK OF HIV

http://www.icwea.org/2017/03/who-releases-guidance-on-hormonal-contraceptive-eligibility-for-women-living-at-high-risk-of-hiv/ On March 2, 2017, World Health Organization (WHO), released updated recommendations concerning the use of hormonal contraceptive methods by women at high risk of HIV. The recommendations for use…

Continue ReadingWHO RELEASES GUIDANCE ON HORMONAL CONTRACEPTIVE ELIGIBILITY FOR WOMEN LIVING AT HIGH RISK OF HIV